Masuoka K. Lorianne

Insider Reports History

Entity
Individual
Location
C/O Nektar Therapeutics, 201 Industrial Road, San Carlos, CA
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Masuoka K. Lorianne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Medical Officer Stock option (right to buy) 285K Jan 22, 2024 Direct
DiaMedica Therapeutics Inc. Chief Medical Officer Voting Common Shares, no par value per share 0 $2.80 Jan 22, 2024 Direct
OPIANT PHARMACEUTICALS, INC. Director Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Director Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct

Insider Reports Filed by Masuoka K. Lorianne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jan 22, 2024 1 $0 4 Jan 23, 2024 Chief Medical Officer
DMAC DiaMedica Therapeutics Inc. Jan 22, 2024 0 $0 3 Jan 23, 2024 Chief Medical Officer
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 3 -$80K 4 Mar 3, 2023 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jun 14, 2022 1 $0 4 Jun 14, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jun 15, 2021 1 $0 4 Jun 16, 2021 Director